Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 26Genitourinary 10Other hematologic neoplasm 5Lymphoid 5Thoracic 4Gynecologic 4Other solid neoplasm 3Dermatologic 3Tumor-Agnostic 2Sarcoma 2Plasma cell 2Head & Neck 2Gastrointestinal 2CNS 2

Conditions

Solid Tumour 1Advanced Solid Tumours 1Advanced Solid Malignancy 1

Interventions

Cisplatin 145pembrolizumab 129Carboplatin 125Injections 108Pemetrexed 97Paclitaxel 97Gemcitabine 85Irinotecan 75Nivolumab 71Cyclophosphamide 71Docetaxel 68Bevacizumab 57Oxaliplatin 49Fluorouracil 48atezolizumab 46Capecitabine 46Etoposide 42Leucovorin 41tislelizumab 40toripalimab 36fludarabine 32Ipilimumab 30Drug Therapy 30Topotecan 29durvalumab 28Vincristine 27Early Intervention, Educational 27Radiotherapy 26Interviews as Topic 26Specimen Handling 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × capivasertib × Other solid neoplasm × Clear all
NCT04958226 2024-01-25

A Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid Tumours

AstraZeneca

Phase 1 Completed
21 enrolled
Other solid neoplasm

Solid Tumour

NCT04742036 2022-08-19

Capivasertib China PK Study

AstraZeneca

Phase 1 Completed
16 enrolled
Other solid neoplasm

Advanced Solid Tumours

NCT01353781 2016-04-26

Open Label Phase 1 Study in Japan for Patient With Advanced Solid Malignancies

AstraZeneca

Phase 1 Completed
39 enrolled
Other solid neoplasm

Advanced Solid Malignancy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡